Back to Search
MICHAEL CHAMBERLAIN, D.O.
D.O.
Ophthalmology Physician
NPI: 1366757387IndividualAccepts Medicare
Education
OTHER
Class of 2009
Research & Publications (20)
Salvage therapy with single agent bevacizumab for recurrent glioblastoma.
PMID 19593660·J Neurooncol·2010
3-trial
Natural History of CNS Relapse in Aggressive Non-Hodgkin's Lymphoma: What Have We Learned?
PMID 19546401·J Clin Oncol·2009
8-other
Gene-environment interactions and aging visual function: a classical twin study.
PMID 19019448·Ophthalmology·2009
4-observational
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
PMID 19237713·Neurology·2009
8-other
Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma.
PMID 19569246·Cancer·2009
8-other
Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
PMID 19660682·Semin Oncol·2009
6-review
Gender disparity in the rate of partner abandonment in patients with serious medical illness.
PMID 19645027·Cancer·2009
4-observational
Role of genetic factors in lower- and higher-order aberrations--the genes in myopia twin study.
PMID 19321935·Ophthalmic Res·2009
4-observational
Cilengitide: does it really represent a new targeted therapy for recurrent glioblastoma?
PMID 19255301·J Clin Oncol·2009
8-other
Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.
PMID 18820836·J Neurooncol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 244 S. GATEWAY PL., SUITE 401
JENKS, OK 74037 - Phone
- (918) 747-2020
Quick Facts
- NPI
- 1366757387
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile